Gut microbiota of patients with EGFR-mutant non-small cell lung cancer (NSCLC)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/DRP013391
下载链接
链接失效反馈官方服务：
资源简介：
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective for EGFR-mutant NSCLC, but biomarkers for prognosis and side effects are limited. This study investigates the gut microbiota's potential as a biomarker for EGFR-TKI-induced diarrhea and treatment efficacy in EGFR-mutant NSCLC patients.
创建时间：
2025-06-21
